Axonyx Inc (AXYX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Axonyx Inc (AXYX)

An SI Board Since October 2003

Posts	SubjectMarks	Bans	Symbol
22	5	0	AXYX

Emcee: VIXandMore	Type: Unmoderated

Introduction Market Data Compact

Axonyx Inc. is a biopharmaceutical company engaged in the business of acquiring and developing novel post-discovery central nervous system drug candidates primarily in memory and cognition. The Company acquires patent rights to central nervous system pharmaceutical compounds that may have potential market impact, and works to advance the compounds via pre-clinical and clinical development towards regulatory approval. Axonyx has worldwide exclusive patent rights to three main classes of therapeutic compounds designed for the treatment of Alzheimer's disease (AD), Mild Cognitive Impairment and related diseases. It has also acquired patent rights to a class of potential therapeutic compounds designed for the treatment of prion-related diseases. Axonyx licensed these patent rights from New York University and, via a sublicense, from the National Institutes of Health/National Institute on Aging. The Company has co-inventorship rights to Posiphen, which was developed for the treatment of AD.

The CEO said on 9/30/03 that Phensarine "could be fast-tracked."
biz.yahoo.com

Another SI thread, "AXYX - Miscellaneous," is not intented as a discussion thread, but as "a filing cabinet for abstracts and
misc. writings related to AXYX's work
in AD."
Subject 53918

The stock hit the low $20's in 2000, was below $1 as late as April '03, and pushed over $5 twice in Sept and Oct '03.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
22	JF, Sorry... I do not follow really what any stock does anumore... Just the cha	Chartgod	-	2/12/2005
21	What a beating. Anyone know what other drugs AXYX has in the pipeline?	Jagfan	-	2/8/2005
20	Will someone wake me up...when the ask on this gets to 2.04 again (if it does )	Chartgod	-	2/7/2005
19	That would be my take on it, since early Phenserine studies showed lower side ef	Jagfan	-	1/26/2005
18	But the J&J news should be positive for AXYX shouldn't it?	fmikehugo	-	1/26/2005
17	Thanks. After doing a little digging I came up with two possible reasons for the	Jagfan	-	1/26/2005
16	The Yahoo board was hysterical today, but in all the garbage there were a few id	fmikehugo	-	1/26/2005
15	Anyone have any thoughts why it dropped almost 10% today??	Jagfan	-	1/25/2005
14	Clinical data are due to be reported first quarter of 2005 for Phenserine, Alzhe	Jagfan	-	1/5/2005
13	<b>Can Axonyx Help Treat Alzheimer's?</b> businessweek.com OCT	Glenn Petersen	-	10/4/2004
12	AD Conference abstract getter thingie ... Message 20277154 also, there was on	John McCarthy	-	7/2/2004
11	IRT Tahoo 8986....Thanks for the nutshell on AXYX. I love reading briefs like th	Lawrence Burg	-	6/24/2004
10	Yes. DBAB is Duetsche Bank Alex Brown. They've had a large quantity of share	Lawrence Burg	-	6/23/2004
9	10:06AM Axonyx announces $20 mln private placement (AXYX) 6.91 -0.33: Co announc	VIXandMore	-	5/4/2004
8	Feurstein mentions AXYX as possible acquisition candidate for FRX, pushing AXYX	VIXandMore	-	4/23/2004
7	Adam Feuerstein, from the street.com is following axyx. Articles dates 2/3/04, 1	wontgetfooledagin	-	2/4/2004
6	Motley Fool on AXYX fool.com Big Break for a Small Biotech? By David Nierenga	VIXandMore	-	2/3/2004
5	Axonyx Announces $50 Million Private Placement of Common Stock and Warrants NEW	VIXandMore	-	1/8/2004
4	09:36 AXYX called #1 near-term idea at Sandler; target $15 (4.97 +0.07) Sandler	VIXandMore	-	1/7/2004
3	Moooooooo! Got beef? Trying AXYX cause of the patents. ;) Jack	Jack Hartmann	-	12/24/2003
2	Bill, Not a bad one really, longer term.... An entry at 4.25 - 4.30 looks ve	Chartgod	-	10/18/2003
1	AXYX up 10% today, approaching 52 week high On strong volume	VIXandMore	-	10/16/2003

Go to reply# or date (mm/dd/yy):